Inhibitors

(Difference between revisions)

Revision as of 10:16, 17 October 2021

@@ Line 1: / Line 1: @@
 <StructureSection load='2f1o.pdb' size='350' frame='true' side='right' scene='2f1o/Com_view/2'  caption='NADPH dehydrogenase complex with FAD and inhibitor dicoumarol [[2f1o]]'>
-This is a default text for your page '''Inhibitors'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
+*[[AChE inhibitors and substrates]]
-You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
+*[[Drug Metabolism by CYP450 Enzymes]]
+*In a ''substrate reduction therapy'' a small molecule inhibitor ([[Acid beta-glucosidase with N-nonyl-deoxynojirimycin|Zavesca™]]) is used to inhibit the synthesis of the accumulated glucosylceramide.
-== Function ==
-== Disease ==
-== Relevance ==
-== Structural highlights ==
-This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
 </StructureSection>
 == References ==
 <references/>